Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial

BACKGROUND: Testosterone deficiency (TD) is a prevalent condition, especially in men ≥45 years old, and testosterone therapy (TTh) can improve the quality of life in these patients. AIM: To evaluate the safety profile of compounded subcutaneous testosterone pellets and to compare the efficacy betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kresch, Eliyahu, Lima, Thiago Fernandes Negris, Molina, Manuel, Deebel, Nicholas A, Reddy, Rohit, Patel, Mehul, Loloi, Justin, Carto, Chase, Nackeeran, Sirpi, Gonzalez, Daniel C, Ory, Jesse, Ramasamy, Ranjith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pharmacotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022718/
https://www.ncbi.nlm.nih.gov/pubmed/36936900
http://dx.doi.org/10.1093/sexmed/qfad007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022718/
https://www.ncbi.nlm.nih.gov/pubmed/36936900
http://dx.doi.org/10.1093/sexmed/qfad007

Ejemplares similares